These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22495870)

  • 1. Daptomycin resistance in prosthetic joint infections.
    Sivakumar B; Vijaysegaran P; Chaudhuri A; Crawford S; Ottley M
    Orthopedics; 2012 Apr; 35(4):e603-6. PubMed ID: 22495870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
    Kanafani ZA; Corey GR
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN; Alder J; Thorne GM; Tally FP
    J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful clinical use of daptomycin-impregnated bone cement in two-stage revision hip surgery for prosthetic joint infection.
    Cortes NJ; Lloyd JM; Koziol L; O'Hara L
    Ann Pharmacother; 2013 Jan; 47(1):e2. PubMed ID: 23324502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
    Carpenter CF; Chambers HF
    Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cSSTIs: the role of daptomycin.
    Garau J
    Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
    Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
    Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
    Mathiesen L; Midtvedt T; Solberg CO
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2383-4. PubMed ID: 16998552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin.
    Enoch DA; Bygott JM; Daly ML; Karas JA
    J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.
    Johnson A
    Future Microbiol; 2006 Oct; 1(3):255-65. PubMed ID: 17661638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin: a review 4 years after first approval.
    Sauermann R; Rothenburger M; Graninger W; Joukhadar C
    Pharmacology; 2008; 81(2):79-91. PubMed ID: 17940348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
    Rao N; Regalla DM
    Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin: pharmacology and clinical use.
    Kosmidis C; Levine DP
    Expert Opin Pharmacother; 2010 Mar; 11(4):615-25. PubMed ID: 20163272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.